Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone for Bipolar Disorder and Alcohol Dependence
NCT00223275Phase 4Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- May 2005
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in alcohol dependence comparing Naltrexone with Placebo (2 arms). Primary endpoints: Reduction in alcohol use at 12 weeks and Reduction in alcohol craving at 12 weeks. Started May 2005; status: completed.
02
Drugs
naltrexone
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT00223275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00223275.